Ocular Therapeut (OCUL)
6.01 x 1 7.20 x 1
Post-market by (Cboe BZX)
6.36 -0.64 (-9.14%) 04/04/25 [NASDAQ]
6.01 x 1 7.20 x 1
Post-market 6.37 +0.01 (+0.16%) 16:05 ET
for Fri, Apr 4th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -193,506 | -80,736 | -71,038 | -6,553 | -155,636 |
| Depreciation Amortization | 3,786 | 2,983 | 2,109 | 2,421 | 2,773 |
| Accounts receivable | -6,209 | -4,854 | -190 | -8,883 | -9,704 |
| Accounts payable and accrued liabilities | -318 | 583 | -621 | 1,796 | -452 |
| Other Working Capital | -10,230 | -7,411 | 1,349 | -2,901 | 1,175 |
| Other Operating Activity | 71,800 | 19,201 | 8,788 | -51,430 | 108,290 |
| Operating Cash Flow | $-134,677 | $-70,234 | $-59,603 | $-65,550 | $-53,554 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,288 | -6,087 | -3,715 | -1,194 | -841 |
| Investing Cash Flow | $-1,288 | $-6,087 | $-3,715 | $-1,194 | $-841 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 2,000 | 0 | 0 | N/A |
| Debt Issued | 0 | 82,474 | 0 | 3,722 | 3,201 |
| Debt Repayment | 0 | -26,125 | 0 | -4,167 | -3,201 |
| Common Stock Issued | 332,110 | 118,663 | 1,454 | 3,571 | 228,014 |
| Other Financing Activity | 0 | -7,184 | 0 | -275 | 0 |
| Financing Cash Flow | $332,110 | $169,828 | $1,454 | $2,851 | $228,014 |
| Beginning Cash Position | 197,571 | 104,064 | 165,928 | 229,821 | 56,201 |
| End Cash Position | 393,716 | 197,571 | 104,064 | 165,928 | 229,821 |
| Net Cash Flow | $196,145 | $93,507 | $-61,864 | $-63,893 | $173,620 |
| Free Cash Flow | |||||
| Operating Cash Flow | -134,677 | -70,234 | -59,603 | -65,550 | -53,554 |
| Capital Expenditure | -1,288 | -6,087 | -3,715 | -1,194 | -841 |
| Free Cash Flow | -135,965 | -76,321 | -63,318 | -66,744 | -54,395 |